Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials
暂无分享,去创建一个
B. Rochwerg | R. Mustafa | T. Agoritsas | A. Izcovich | R. Brignardello-Petersen | D. Zeraatkar | R. Siemieniuk | D. Chu | A. Khamis | L. Ge | P. Vandvik | S. McLeod | J. Bartoszko | E. Kum | R. Siemieniuk | Shelley McLeod